Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study

Background: The benefits of novel androgen receptor axis-targeted agents (ARATs) on oncological outcomes in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in real-world settings are unclear. Methods: This multi-institutional retrospective study included 178 patients with...

Full description

Bibliographic Details
Main Authors: Naoki Fujita, Shingo Hatakeyama, Ryuji Tabata, Kazutaka Okita, Koichi Kido, Itsuto Hamano, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Yuichiro Suzuki, Takahiro Yoneyama, Yasuhiro Hashimoto, Satoshi Sato, Chikara Ohyama
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Prostate International
Subjects:
nmCRPC
Novel ARATs
Oncological outcomes
PSA doubling time
Real-world
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888223000739

Internet

http://www.sciencedirect.com/science/article/pii/S2287888223000739

Similar Items